Related Experiment Video
Updated: May 31, 2026
09:03
Manufacture and Drug Delivery Applications of Silk Nanoparticles
Published on: October 8, 2016
Spider silk-based gene carriers for tumor cell-specific delivery
Keiji Numata1, Michaela R Reagan, Robert H Goldstein
1Department of Biomedical Engineering, Tufts University, 4 Colby Street, Medford, Massachusetts 02155, United States.
Bioconjugate Chemistry
|July 12, 2011
Summary
Novel silk-based nanoparticles carrying DNA show enhanced targeting to tumor cells. These engineered silk-protein complexes with tumor-homing peptides offer a promising platform for targeted gene delivery.
Area of Science:
- Biomaterials Science
- Nanotechnology
- Gene Therapy
Background:
- Developing effective nonviral gene delivery systems is crucial for targeted therapies.
- Silk proteins offer a biocompatible scaffold for drug and gene delivery applications.
- Tumor-homing peptides (THPs) can enhance the specificity of delivery systems to cancer cells.
Purpose of the Study:
- To prepare and characterize novel nanoscale silk-based ionic complexes for targeted plasmid DNA (pDNA) delivery.
- To evaluate the enhanced tumor cell specificity of these complexes by incorporating specific THPs (F3 and CGKRK).
- To assess the potential of these engineered silk-protein complexes as a versatile platform for nonviral gene delivery.
Main Methods:
- Genetically engineered silk proteins containing poly(L-lysine) and THPs were prepared using Escherichia coli.
- Nanoscale complexes (150-250 nm) of these silk proteins with pDNA were formed.
- In vitro and in vivo transfection experiments were conducted using MDA-MB-435 melanoma and MDA-MB-231 breast tumor cells.
- Non-tumorigenic MCF-10A cells were used as a control for specificity studies.
Main Results:
- Silk-based pDNA complexes incorporating F3 and CGKRK THPs demonstrated significantly enhanced target specificity to tumor cells.
- The engineered silk-protein complexes successfully delivered pDNA to target tumor cells.
- Studies confirmed the tumor-specific delivery capabilities of the bioengineered silk systems.
Conclusions:
- The combination of bioengineered silk delivery systems and THPs provides a versatile platform for targeted nonviral gene delivery.
- These novel nanoscale complexes show promise for enhancing the efficacy and specificity of gene therapy.
- Further development of these silk-based nanoparticles could lead to improved cancer treatments.
Related Concept Videos
00:59Gene Therapy
Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be inserted. The...
01:24Site-Targeted Drug Delivery Systems: Polymeric Carriers
Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...